Publications (78) Alberto Esteban Fernández publications

filter_list

2025

  1. Age-based analysis of the SEC-Excelente-HF registry: clinical characteristics and prognosis of a prospective cohort of heart failure patients

    European Geriatric Medicine

  2. Analysis of clinical features and prognosis in cardiac amyloidosis patients from Spanish hospitals (2016-2021)

    Revista Clinica Espanola, Vol. 225, Núm. 3, pp. 131-139

  3. Celebrating a decade of the HFA young community: Achievements and future directions by the HFA Young Committee

    ESC Heart Failure, Vol. 12, Núm. 4, pp. 2702-2710

  4. Clinical characteristics and impact of QRS complex duration in patients with complete left bundle branch block

    REC: CardioClinics, Vol. 60, Núm. 3, pp. 229-231

  5. Clinical characteristics and management of patients with cardiac amyloidosis in clinical practice: an analysis of a cohort of 33 patients

    Archivos de Cardiologia de Mexico

  6. Clinical utility and safety of finerenone in patients with heart failure: Rationale and design of FINE registry

    ESC Heart Failure, Vol. 12, Núm. 4, pp. 3163-3172

  7. Comprehensive analysis of clinical characteristics, management, and prognosis in patients with dilated cardiomyopathy discharged from Spanish hospitals

    Hellenic Journal of Cardiology

  8. Different impact of chronic kidney disease in older patients with heart failure according to frailty

    European Journal of Internal Medicine, Vol. 132, pp. 90-96

  9. Early initiation of SGLT2 inhibitors within guideline-directed medical therapy and outcomes in newly diagnosed heart failure patients

    BMC Cardiovascular Disorders, Vol. 25, Núm. 1

  10. Edoxaban Safety and Effectiveness in Real-Life Patients with Heart Failure and Atrial Fibrillation: EMAYIC Study

    Journal of Clinical Medicine, Vol. 14, Núm. 20

  11. Effectiveness and safety of vericiguat in patients with heart failure and reduced ejection fraction: a narrative review of real-world evidence studies

    Frontiers in Cardiovascular Medicine, Vol. 12

  12. Eligibility for finerenone in real-world patients with diabetes and chronic kidney disease: Insights from the FIDELITY pooled analysis

    Nefrologia

  13. Evaluation, Management and Therapeutic Approach of Cardiovascular–Kidney–Metabolic Syndrome: A Multidisciplinary Delphi Expert Consensus

    Journal of Clinical Medicine, Vol. 14, Núm. 24

  14. How to treat patients with heart failure with midrange left ventricular ejection fraction

    REC: CardioClinics, Vol. 60, Núm. 3, pp. 231-233

  15. Influence of patient characteristics and discharge destination on circulatory system diseases readmissions among older heart failure patients

    Archives of Gerontology and Geriatrics, Vol. 129

  16. Justification and design of the BOCADOS-IC study: Nutritional management in adults followed in Spanish hospitals for heart failure

    Revista Espanola de Geriatria y Gerontologia, Vol. 60, Núm. 2

  17. National survey on the management of iron deficiency with iron carboxymaltose in heart failure in Spain

    REC: CardioClinics

  18. Tachycardia-induced cardiomyopathy in de novo heart failure: prevalence, short-term outcomes, and the role of guideline-directed therapy in ejection fraction improvement

    Clinical Research in Cardiology

2024

  1. 6113-16. Diseño y justificación de la creación de una plataforma nacional multicéntrica para el estudio de la enfermedad inflamatoria del miocardio: cohorte Pre-MYO

    SEC 2024 - El Congreso de la Salud Cardiovascular

  2. Clinical profile of an unselected population with heart failure treated with vericiguat in real life: differences with the VICTORIA trial

    Frontiers in Cardiovascular Medicine, Vol. 11